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Diabetes mellitus is a chronic disease with several comorbidities. Currently used synthetic medicines have various side 
effects. Herbal medicines are being widely used for management of diabetes. The present study was conducted to evaluate 
the effect of poly herbal formulation (PHF) (mixture of Citrullus colocynthis, Syzygium cumini and Holarrhena 
antidysenterica) in diabetic rats. We evaluated enzyme inhibition activity of PHF by ELISA and anti-hyperglycemic action 
was assessed in streptozotocin induced diabetic rats. Animals were divided into 5 groups, i.e., blank, negative control, 
standard control and PHF 250 and 500 mg/kg dosage respectively. Blood glucose level assessed through one touch method 
blood glucose monitoring system. The statistical analysis was performed by using one-way ANOVA p value of ≤0.05 was 
considered significant. Results of study indicated that PHF sufficiently inhibited DPPH at 0.5 mg/mL and serial dilutions 
with IC50 of 197 µg/mL while α- glucosidase inhibition assay showed marked inhibition of PHF at 0.5 mg/mL and serial 
dilutions with IC50 of 235 µg/mL. Oral intake of PHF reduced blood glucose level, serum triglyceride and cholesterol levels 
in wistar albino rats in dose dependent manner. Considering the multidirectional effects of PHF, it is concluded that PHF 
may be a therapeutic option in management of diabetes. 
Keywords: Antidiabetic, Antioxidant, Poly herbal formulation 
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Diabetes Mellitus (DM) is a chronic disease having 
significant morbidity and mortality. Its risk is 
increasing tremendously all over the world
1
. DM is 
one of the most commonly found diseases affecting 
people of both civilized and non-civilized countries. It 
is caused by abnormal metabolism of carbohydrates, 
proteins and lipids that leads to severe complications
2
. 
It is presumed that DM will be the one of the largest 
non-contagious disease in the world by year 2025 
with the major diabetic population in developing 
world
3
. Lacking of systematized health care system in 
developing countries causes patients of chronic 
diseases like DM among the worst sufferers in 
community. Moreover, very few people has access to 
the modern medicine and they rely mostly on 
medicinal flora of their native lands for management 
of diabetes and its complication
4
.  
Herbal medicines are being widely used for 
combating DM. Several individual herbs have 
reported anti-hyperglycemic effect in animal and 
human trials
5
 and a number of marketed herbal 
preparation having anti-diabetic activity
6
. Herbal 
preparations are the basis for finished herbal products 
and may include comminuted or cut herbal materials, 
or extracts, tinctures and fatty oils of herbal materials. 
They are produced by extraction, fractionation, 
purification, concentration, or other physical or 
biological processes
7
. 
A herbal formulation having antioxidant, anti-
hyperglycemic, hypolipidemic effects is the most 
reliable strategy to combat DM as it may be caused by 
reactive oxygen species such as hydroxyl radicals 
——————— 
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(OH) and superoxide anion radical (O2), etc., and DM 
is mostly associated with hyperlipidemia
8
. 
Citrullus colocynthis, Syzygium cumini and 
Holarrhena antidysenterica are the plants with reported 
antihyperglycemic, hypolipidemic and antioxidant 
potential. Moreover, they are used traditionally to treat 
diabetes. (Table 1) C. colocynthis is among the most 
common traditional plants used as remedy against 
diabetes mellitus in the subcontinent since long.  
C. colocynthis fruit extract has reported in vitro 
antioxidant potential
9,10
, in vitro α-glucosidase 
inhibition
11
, in vivo anti-hyperglycemic effects
12,13
.  
A randomized clinical trial also proved C. Colocynthis 
fruit capsules (100 mg) as an effective and safe anti-
diabetic intervention compared to placebo
14
. 
The anti-diabetic activity of S. cumini has been 
studied since long for its anti-diabetic properties the 
pulp bark and seeds, have shown potent anti-diabetic 
actions
15,16
. Different extracts of seeds of S. cumini are 
the most studied and effective hypoglycemic agent 
reported in study of different experimental models
17-21
. 
S. cumini seeds are also said to prevent the secondary 
complications induced by diabetes like nephropathy, 
gastropathy, neuropathy and diabetic cataract
22
.  
S. cumini showed promising hypoglycemic effects 
when studied in human subjects
23
. Moreover,  
S. cumini seeds have radical scavenging properties 
against DPPH, superoxide and hydroxide  
scavenging assays
24,25
. H. antidysenterica seed extracts  
have significant anti-diabetic effects in vivo
26-28
. 
Hypoglycemic effect of H. antidysenterica seeds on 
streptozotocin induced diabetic rats. and inhibit α - 
glucosidase in vitro
29
. No metabolic toxicity was 
reported in kidneys and liver
28
.  
There is a need to search compounds  
having antioxidant and anti-diabetic potential  
from herbal sources to combat DM as it may be caused 
by reactive oxygen species such as hydroxyl radicals 
(OH) and superoxide anion radical (O2), etc. Moreover, 
the present synthetic drugs have many side effects  
such as chronic tissue damage, hypoglycemia and 
weight gain
30
. 
The primary objective of study was to formulate 
and validate an anti-diabetic poly herbal formulation 
(PHF) consisted of three valuable anti-diabetic  
plants namely C. colocynthis (Fruit), S. cumini and  
H. antidysenterica (seeds). Secondary objective of 
study was to check effect of PHF on triglyceride and 
cholesterol levels.  
 
Methodology 
 
Chemicals 
Streptozotocin (Bio word), Glibenclamide (SANOFI, 
Pakistan, Limited), Galoxose D (Glaxo Smith Kline), 
Triglycerides liquicolor, Cholesterol liquicolor (Human 
Diagnostic, Germany), Ketamine (Budapest, Hungary) 
and Xylazine (Prix Pharmaceutica, Lahore),  
α-glucosidase, Acarbose, Ascorbic acid and DPPH 
(Sigma Aldrich).  
 
Plant Material and Extraction 
The plant materials were collected from nearby 
market of Bahawalpur. They were identified and 
authenticated by botanist from Department of Botany, 
The Islamia University of Bahawalpur (Voucher no 
2201/L.S) and deposited in herbarium, IUB. The plant 
materials were dried in shade and screened carefully  
to remove any extraneous matter or adulteration.  
They were subjected to coarse grinding using grinder. 
Grounded plant materials were macerated with  
80% methanol for 15 days with frequent stirring.  
After 15 days, soaked plant material was filtered  
first with muslin cloth followed by filtration  
through whatmann filter paper. The process was 
repeated thrice with interval of 15 days. The filtrate  
was subjected to evaporation at low temperature  
(30 to 40°C) and under reduced pressure using  
rotary evaporator (Heidolph Laborota 4000 efficient, 
Germany). A crude thick viscous paste of each  
plant was obtained. These were crude extracts of 
plants
31
. 
 
Poly Herbal Formulation (PHF) 
PHF was prepared by taking extracts of S. cumini 
(seeds), H. antidysenterica (seeds), C. collocynthis 
(fruit) in specific ratio based on Pari L & Saravanan R 
methodology
32
. At last PHF was weighed, labeled and 
stored in air tight amber colored glass container for 
further in vitro and in vivo experiments. For in vivo 
experiment, the dose of PHF was selected by 
Table 1 — Plants used in formulation 
Sr. Plants Reported activities 
1. Citrullus colocynthis Antioxidant9,10, 
anti-hyperglycemic12,13, 
antihyperlipidemic47 
2. Syzygium cumini Antioxidant24,25, 
anti-hyperglycemic17-21, 
antihyperlipidemic48 
3. Holarrhena antidy  
senterica 
Antioxidant49, 
anti-hyperglycemic26-28, 
antihyperlipidemic28 
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performing an effective dose fixation study method 
with slight modification
33
. 
 
In vitro Antioxidant Assay 
 
DPPH free radical scavenging Assay 
The scavenging activity of herbal formulation was 
checked with 2, 2 diphenyl 1, picrylhydrazyl radical 
by a micro assay with some modifications
34
. Total 
assay volume was 100 μL. 90 μL of DPPH solution 
and 10 μL different serial dilutions of herbal 
formulation were placed in wells of a 96 well micro 
plate. The wells containing 90 μL DPPH and 10 μL of 
methanol was used as negative control. Ascorbic acid 
was taken as standard control. The whole process was 
done in triplicate. The reaction mixture was placed for 
30 min at 37°C. The absorbance was measured at  
517 nm by using Bio-tech ELISA micro plate reader. 
The percentage inhibition was taken as follows:  
Scavenging activity % = 100 – (Af/ Ac) * 100 
Where, 
Ac = Absorbance of negative control 
Af= Absorbance of herbal formulation 
 
In vitro Anti-diabetic Assay 
 
α-glucosidase Inhibition Assay 
α-glucosidase inhibitory assay was performed with 
the method of
35
 with some modification. Total assay 
volume was 100 µL. 10 µL of PHF (serial dilutions), 
10 µL of α-glucosidase (0.5 unit/mL) and 70 µL of 
0.1 M phosphate buffer pH 6.8 per well of 96 well 
plate were incubated for 15 min at 30°C. 10 µL of  
p-Nitrophenyl-α-D-glucopyranoside substrate solution 
was added and incubated for an additional 30 min. 
Absorbance was measured with HT BioTek 
microplate reader at 400 nm. The reaction system 
without sample (only methanol) was used as control 
and acarbose was used as standard control. Each 
experiment was conducted in triplicate. The enzyme 
inhibitory rates of samples were calculated as follows: 
% inhibition= 100- (Af/ Ac) * 100 
Where, 
Ac = Absorbance of negative control 
Af= Absorbance of herbal formulation 
 
In vivo Anti- diabetic Activity 
 
Experimental Animals  
Male Wistar Albino rats weighing from 200-250 g 
were obtained from animal house of the Faculty of 
Pharmacy and Alternative Medicine, The Islamia 
University of Bahawalpur, Pakistan. All rats were 
acclimatized at room temperature of 20-22°C and at 
45-55% relative humidity for 12 h, each of dark and 
light cycle. Rats were placed in polycarbonate cages 
(47×34×18 cm
3)
 with a maximum of 6 animals per 
cage. They were fed with a standard diet and water 
provided ad libitum. The experiment performed 
followed ethics declared by Animal Welfare Division 
of the Ministry of Environment & Forest, Council of 
International Organization of Medical Sciences. The 
whole manuscript complied according to the ARRIVE 
guidelines
36
. The experimental protocol was approved 
from Pharmacy Research Ethics committee (PREC), 
The Islamia University Bahawalpur Ref No. 37-
2015/PREC date 08-09-2015 and is in accordance 
with the guidelines of committee for the purpose of 
experiments on animals.  
 
Experimental Protocol 
The animals were divided in to 5 different groups 
and each group contain 6 animals. Sample size was 
calculated through "resource equation" method
37
. 
Twelve hours before the experiment, the animals 
were fasted overnight but allowed for free access to 
water. Diabetes was induced by intra peritoneal 
injection of STZ to animals by the methodology of 
Zhang et al
38
. Normal rats were injected with the 
equivalent volume of citrate buffer. STZ-induced 
diabetic animals with diabetic status (Fasting Blood 
Glucose ≥ 250 mg/dL) for 2 weeks were taken for the 
study. After confirmation of diabetes, animals were 
allowed to stabilize for one week. The treatment was 
started on the same day considering it day one of the 
study. The vehicle, glibenclamide and poly herbal 
preparation were given orally through intra gastric 
tube for 14 days daily. 
 
Blood Sampling and Biochemical Analysis 
Blood samples were collected from the rat tail vein. 
The blood glucose (BG) levels of the rats were 
monitored daily by using one-touch blood glucose 
monitoring system. The hypoglycemic effect in blood 
glucose level was monitored on 0, 1
st
, 5
th
, 8
th
, 11
th
, and 
14
th
 day of induction. After 14
th
 day of treatment,  
rats were fasted overnight. The blood for further 
biochemical screening was collected by cardiac 
puncture (anesthetized with 0.2 mL/100 g Ketamine/ 
Xylazine combination) and allowed to clot for 15 min. 
Serum was separated by centrifuging blood at 4000 
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rpm for 10 min. The animals were gently sacrificed 
by cervical decapitation.  
Biochemical analysis for cholesterol and triglyceride 
was performed by using standard kits. The results 
were then obtained by running the respective samples, 
standards and blanks on micro lab 300 (Merck, 
Germany). 
 
Statistical Analysis  
All the results obtained were represented as Mean 
± SEM. One way Analysis of variance for repeated 
measures (ANOVA) followed by LSD post hoc test 
was used to assess statistical significance. p value 
≤0.05 was considered significant. 
 
Results  
A preliminary phytochemical analysis of PHF 
showed the presence of phenols, flavonoids, tannins, 
saponins and alkaloids. (Table 2) 
Results of DPPH inhibition assay displayed that 
PHF was able to decolorize DPPH and therefore 
possess antioxidant potential by trapping free radical. 
DPPH is purple in color and contains an odd electron. 
When hydrogen from an antioxidant compound binds 
to odd electron of DPPH to form DPPH-H, DPPH 
turns to yellow
25
. PHF sufficiently inhibited DPPH at 
0.5 mg/mL and serial dilutions with IC50 of 197 
µg/mL. Results of in vitro α- glucosidase inhibition 
assay showed marked inhibition of PHF at 0.5 mg/mL 
and serial dilutions with IC50 of 235 µg/mL. (Fig. 1) 
Dose fixation studies indicated the non-toxic nature 
of PHF in the dose range between 1 and 5 g/kg body 
weight in normal rats. There was no mortality or side 
effects in the rats treated with PHF at all the doses. 
500 mg/kg was selected as the highest dose (1/10th of 
highest dose of 5 g/kg) for antihyperglycemic activity. 
The rats were also treated with 250 mg/kg dose of PHF.  
The baseline characteristics of all the rats included 
for anti-diabetic study were same. (Table 3) Intra 
peritoneal injection of streptozotocin during in vivo 
experiment caused hyperglycemia in rats, as indicated 
by drastic increase in serum glucose levels. Initially 
serum glucose levels were insignificantly decreased 
after PHF administration but continuous administration 
for 11 and 14 days showed a marked significant 
decrease in serum glucose levels. PHF (250 mg/kg) 
showed a gradual decrease in blood glucose level 
from 355.3±3 mg/dL to 313.5±2 mg/dL, 281.8±42 
mg/dL, 256.0 ± 4 mg/dL at 8
th
, 11
th
 and 14
th
 day of 
administration respectively. Moreover, 11 and 14 day 
treatment of PHF (250 mg/kg) was found to be as 
Table 2 — Preliminary phytochemical analysis 
Sr. No Chemical constituents Tests Name Result of sample 
1 Saponin Froath test + 
Emulsifying properties + 
2 Anthraquinone glycosides Borax test + 
Bromine water test + 
Nitric acid test + 
Borntrager test + 
3 Phenolic glycosides Erdmann’s test + 
4 Alkaloids Mayer’s reagent + 
Wagner’s reagent + 
Hager’s reagent + 
Dragendorff’s reagent + 
5 Tannins Ferric chloride test + 
Bromine water - 
Formalin test - 
Sodium nitrite test - 
6 Flavonoids Sodium hydroxide test + 
 
 
Fig. 1 — Antioxidant and α- glucosidase inhibitory potential of 
PHF (serial dilutions) and standards. DPPH Inhibition standard 
(ascorbic acid), α- glucosidase standard (Acarbose). 
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effective as glibenclamide (600 µgm/kg) which was 
taken as standard control of the study as shown in 
Table 4. 
Similar to the above results, a time-dependent 
decrease in blood glucose levels was also observed 
after administration of PHF (500 mg/kg). 8-day 
administration of PHF at 500 mg/kg insignificantly 
reduced blood glucose levels in rats, though still 
above the normal control level, while 11 or 14 day 
treatment with PHF at 500 mg/kg was effective 
enough for a thorough recovery, which was 
significantly lower than that after 8-day administration. 
Administration with glibenclamide at 600 µg//kg for 8 
days reduced blood glucose levels markedly and 
further significant decrease in the levels was achieved 
when more treatments were given.  
PHF lowered the serum triglyceride and cholesterol 
levels in diabetic rats significantly as compared to 
negative control. (Fig. 2 & Fig. 3) 
 
Discussion 
The present study reveals that the PHF possess 
antioxidant and α- glucosidase inhibition in vitro and 
was able to significantly reduce blood glucose levels 
in rats. Moreover, PHF has significant impact on 
serum cholesterol and triglycerides. The activities of 
the individual plant components of the PHF are well 
known for their antioxidant, antihyperglycemic and 
anti hyperlipidemic effects. (Table 1)  
Preliminary phytochemical analysis of PHF showed 
presence of antioxidant phytochemicals as alkaloids and 
flavonoids. Previously reported study suggested that 
flavonoids are the main component in plant materials  
Table 3 — Baseline Characteristics of different groups 
Baseline Characteristics  Baseline data of different groups. 
Blank Negative control Standard control PHF (250) PHF (500) 
Body weight (g)  
(Mean ±S.E.M) 
203 ±5 201 ±8 203 ±5 204 ±4 202 ±3 
Blood Sugar level (mg/dL) 
(Mean ± S.E.M)  
118.6 ± 5 123.3 ± 3 126.0 ± 2 122.8 ± 2 120.6 ± 3 
*There is no significant difference between any of the groups.  
 
Table 4 — Time dependentEffect of Poly Herbal Formulation on blood glucose level 
Groups Before Treatment 
Blood Sugar level (mg/dL) 
After Treatment 
Blood Sugar level 
(mg/dL) 
 0 Day 5 day 8th Day 11th Day 14th Day 
Blank 118.6±5 117.8±4 114.1±2# 114.6±3# 118.6±4# 
Streptozotocin 123.3±3 364.6±6 412.3±6 430.6 ±7 395.2±5 
Glibenclamide 126.0±2 355.3±3 290.1±4* 271.8±2† 221.5±2# 
PHF 250 mg/kg 122.8±2 350.1±5 313.5±2^ 281.8±42† 256.0±4† 
PHF 500 mg/kg 120.6±3 351.3±4 320.0±4^ 283.5±3† 258.5±2† 
Note: *p≤0.05, †p≤0.01, #p≤0.001, ^ insignificant compared to negative control. Values are expressed as mean ± SEM (n=6), 0 Day 
reading is normal sugar level of rats before streptozotocin administration, before treatment 5 day reading is after hyperglycemia induction 
reading. 8th to 14th day readings are after medicine administration. 
 
 
Fig. 2 — Effect of PHF on serum cholesterol levels. * p≤0.05 as 
compared to negative control 
 
 
 
Fig. 3 — Effect of PHF on serum triglyceride levels. * p≤0.05 as 
compared to negative control 
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for amelioration of diabetes mellitus and other 
pathophysiologic disorders that are caused by oxidative 
stress
39
. Diabetes is associated with much comorbidity 
including increased superoxide production, lipid 
peroxidation, glycation of the lipoproteins and oxidative 
DNA damage. Antioxidants are helpful in management 
of diabetes and many complications of diabetes can be 
tackled by appropriate antioxidants administration along 
with anti-diabetics
40
.  
α-glucosidase inhibitors are used as a therapeutic 
approach for combating hyperglycemia as it is the key 
enzyme in biosynthesis of glycoproteins and cleavage of 
glycosidic bond
11
. PHF exhibited the strongest inhibition 
of α-glucosidase. This is depicted by low IC50 generated 
however higher than acarbose. The previous studies 
mentioned that an ideal anti-diabetic agent should have a 
strong inhibition of α-glucosidase30. α- glucosidases 
from yeast are maltooligosaccharides hydrolyzes 
heterogeneous substrates such as sucrose. α-glucosidase 
inhibitors decreased postprandial hyperglycemia
11
.  
In vivo experimentation showed a drastic increase 
of blood glucose levels as compared to baseline after 
streptozotocin administration. Low-dose STZ induces 
a mild impairment of insulin secretion and hence 
causes hyperglycemia and symptoms similar to Type 
2 diabetes
38
. 
Oral administration of PHF was able to 
significantly reduce blood glucose levels of diabetic 
rats in a time-dependent manner. However, the onset 
of hypoglycemic action of PHF appeared to be slower 
than that of glibenclamide. Glibenclamide elicit its 
hypoglycemic action on 8
th
 day and decreased the 
elevated blood glucose levels to the significant extent. 
After 11 days or more of PHF administration, there 
was really no significant difference between PHF and 
glibenclamide in lowering blood glucose levels in 
diabetic rats. The mechanism of action of PHF in 
diabetes is not fully understood. The mechanism of 
individual plants was somewhat described in 
literature. S. cumini may have antihyperglycemic 
effects by insulinase inhibition
19
. A study indicated 
the presence of mycaminose (C8H17NO4) in S. cumini 
as an anti-diabetic agent
41
. Beta-pyrazol-1-ylalanine is 
an insulin secretagogue present in C. colocynthis
42
. 
Saponins and glycosidic components in C. colocynthis 
are responsible for its antihyperglycemic action
19
. So 
it can be postulated that PHF may act as secretagogue 
and insulinase inhibitor as individual plants of PHF 
act through this mechanism. Moreover, PHF also 
contain saponins and glycosides (Table 2), that might 
be responsible for its antihyperglycemic action.  
Diabetes is mostly associated with hypertrigly-
ceridemia
43
. Hormone sensitive lipoprotein lipase that is 
responsible for hydrolysis of triglyceride is stimulated 
by insulin under normal circumstances. Increase in  
level of triglyceride occurs when deficiency of insulin  
leads to deactivate the lipoprotein lipase
44,45
. 
Hypertriglyceridemia and hypercholestrolemia is 
accompanied with high risk of coronary heart diseases, 
myocardial infarction, atherosclerosis and stroke
46
. PHF 
showed marked reduction of serum triglycerides and 
cholesterol in addition to hypoglycemia.  
 
Conclusion 
PHF consisted of S. cumini (seeds),  
H. antidysenterica (seeds), C. colocynthis (fruit) has 
significant antioxidant, antihyperglycemic action and 
hypolipidemic potential. So, this herbal formulation can 
be used as an effective treatment option for management 
of diabetes and its related complications. However, firm 
conclusion regarding use of this PHF as therapeutic 
agent can’t be made due to caveat of small sample size 
in current study.  
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